N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.48p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.07
  • 52 Week Low: 0.45
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 30,427
  • Market Cap: £3.95m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
99.80% above the market average99.80% above the market average99.80% above the market average99.80% above the market average99.80% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Book Ratio
64.43% below the market average64.43% below the market average64.43% below the market average64.43% below the market average64.43% below the market average
28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
58.07% above the market average58.07% above the market average58.07% above the market average58.07% above the market average58.07% above the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Chg 3m
54.17% below the market average54.17% below the market average54.17% below the market average54.17% below the market average54.17% below the market average
26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
99.67% below the market average99.67% below the market average99.67% below the market average99.67% below the market average99.67% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
46.48% below the market average46.48% below the market average46.48% below the market average46.48% below the market average46.48% below the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
99% below the market average99% below the market average99% below the market average99% below the market average99% below the market average
93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average93.94% below the sector average
Operating Profit Loss
51.84% below the market average51.84% below the market average51.84% below the market average51.84% below the market average51.84% below the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
80.4% below the market average80.4% below the market average80.4% below the market average80.4% below the market average80.4% below the market average
64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average64.44% below the sector average
Cash
57.7% below the market average57.7% below the market average57.7% below the market average57.7% below the market average57.7% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.48p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.07
52 Week Low 0.45
Volume 30,427
Shares Issued 832.28m
Market Cap £3.95m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.31% below the market average46.31% below the market average46.31% below the market average46.31% below the market average46.31% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average
Value
46.31% below the market average46.31% below the market average46.31% below the market average46.31% below the market average46.31% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average
Income Not Available
Growth Not Available

N4 Pharma Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
10:28 300 @ 0.50p
08:44 2,500 @ 0.45p
08:44 667 @ 0.45p
08:44 6,146 @ 0.45p
08:44 10,614 @ 0.45p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page